| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
25,917 |
24,467 |
$8.19M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
44,430 |
42,681 |
$4.28M |
| 85027 |
|
29,746 |
27,772 |
$413K |
| G0410 |
Group psychotherapy other than of a multiple-family group, in a partial hospitalization or intensive outpatient setting, approximately 45 to 50 minutes |
840 |
86 |
$256K |
| 87400 |
|
6,730 |
6,400 |
$254K |
| 71045 |
Radiologic examination, chest; single view |
7,169 |
6,782 |
$253K |
| 80053 |
Comprehensive metabolic panel |
11,867 |
11,033 |
$223K |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
684 |
112 |
$170K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
6,719 |
6,304 |
$166K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
9,284 |
8,785 |
$158K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
5,067 |
4,904 |
$152K |
| G0411 |
Interactive group psychotherapy, in a partial hospitalization or intensive outpatient setting, approximately 45 to 50 minutes |
457 |
53 |
$152K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
7,687 |
7,183 |
$143K |
| 93975 |
|
613 |
533 |
$142K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
10,883 |
10,269 |
$138K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,983 |
3,858 |
$136K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,369 |
1,325 |
$117K |
| 81001 |
|
14,437 |
13,689 |
$106K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
2,017 |
1,854 |
$96K |
| 87070 |
|
2,944 |
2,849 |
$94K |
| 76801 |
|
815 |
698 |
$89K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
2,995 |
2,907 |
$83K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
2,263 |
2,103 |
$82K |
| 80076 |
|
2,525 |
2,417 |
$78K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
362 |
352 |
$56K |
| 84484 |
|
3,954 |
3,409 |
$54K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
538 |
460 |
$49K |
| 70450 |
Computed tomography, head or brain; without contrast material |
977 |
941 |
$48K |
| 83690 |
|
4,552 |
4,363 |
$41K |
| 84702 |
|
1,842 |
1,601 |
$31K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
953 |
889 |
$31K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,593 |
1,030 |
$27K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
362 |
327 |
$26K |
| 81025 |
|
1,162 |
1,128 |
$13K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
288 |
281 |
$13K |
| J1756 |
Injection, iron sucrose, 1 mg |
17 |
15 |
$9K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
64 |
64 |
$7K |
| 81003 |
|
1,650 |
1,554 |
$6K |
| 83735 |
|
1,028 |
887 |
$6K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,816 |
1,639 |
$5K |
| 87088 |
|
950 |
894 |
$5K |
| 83880 |
|
632 |
591 |
$4K |
| 84703 |
|
536 |
512 |
$4K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
26 |
25 |
$3K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
17 |
15 |
$3K |
| 87040 |
|
1,040 |
632 |
$3K |
| 83605 |
|
895 |
778 |
$3K |
| 86901 |
|
935 |
854 |
$2K |
| 86900 |
|
935 |
854 |
$2K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
25 |
25 |
$2K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
47 |
42 |
$2K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
97 |
96 |
$1K |
| 84112 |
|
13 |
12 |
$1K |
| 82248 |
|
1,386 |
1,338 |
$1K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
313 |
281 |
$977.05 |
| 87077 |
|
187 |
181 |
$802.29 |
| 36415 |
Collection of venous blood by venipuncture |
18,488 |
16,936 |
$704.70 |
| 85730 |
|
489 |
470 |
$628.70 |
| 85610 |
|
763 |
725 |
$622.90 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
13 |
13 |
$509.56 |
| 87186 |
|
189 |
183 |
$369.84 |
| 87800 |
|
16 |
12 |
$366.80 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,190 |
1,124 |
$356.00 |
| 86850 |
|
53 |
50 |
$302.96 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
65 |
54 |
$280.69 |
| 87420 |
|
12 |
12 |
$265.98 |
| 82550 |
|
150 |
131 |
$257.14 |
| 84443 |
Thyroid stimulating hormone (TSH) |
25 |
25 |
$254.08 |
| 71046 |
Radiologic examination, chest; 2 views |
15 |
15 |
$172.44 |
| 85379 |
|
27 |
24 |
$131.51 |
| 82553 |
|
13 |
13 |
$124.43 |
| 87210 |
|
19 |
18 |
$106.19 |
| J7050 |
Infusion, normal saline solution, 250 cc |
17 |
15 |
$96.48 |
| 86140 |
|
28 |
25 |
$62.44 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
59 |
52 |
$43.09 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
783 |
496 |
$39.13 |
| 84100 |
|
16 |
13 |
$5.68 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
13 |
12 |
$5.07 |
| A9270 |
Non-covered item or service |
2,054 |
1,267 |
$0.00 |
| 96361 |
Intravenous infusion, hydration; each additional hour |
54 |
50 |
$0.00 |
| G1003 |
Clinical decision support mechanism medicalis, as defined by the medicare appropriate use criteria program |
484 |
462 |
$0.00 |